Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
STING R224 variant (human, recombinant)
909
CHF
CHF 909.00
In stock
CAY-23593-100100 µgCHF 909.00
Product Details | |
---|---|
Synonyms | Endoplasmic Reticulum Interferon Stimulator; Stimulator of Interferon Genes; TMEM173 |
Product Type | Protein |
Properties | |
Sequence | N-terminally Histidine-tagged human STING R232, K224R mutant purified from E. coli. |
Purity | ≥70% (SDS-PAGE) |
Formulation | 50 mM HEPES, pH 8.0, with 150 mM sodium chloride, and 10% glycerol |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Cayman Chemicals. |
Shipping and Handling | |
Shipping | DRY ICE |
Long Term Storage | -80°C |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
STING R224 variant (human, recombinant) contains amino acids 138-379 of the wild-type variant (R232) with lysine 224 substituted with arginine. Stimulator of interferon genes (STING) is a component of the innate immune response that binds to cyclic dinucleotides, which are bacterial second messengers, leading to activation of NF-κB and transcription of immunomodulatory genes, including type I interferon (IFN). The R232 variant of STING is the most common variant in the human population, found at a frequency of 57.9% in the 1000 Genome Project. The SNP variant H232 is found at a 13.7% frequency. The K224R mutation prevents ubiquitination of STING at position K224, a process which is essential for efficient cytosolic DNA-mediated signaling. Therefore, this mutation disrupts optimal STING trafficking, which inhibits TBK1-mediated IRF3 activation but not NF-κB activation.